IP Library › Assignment 055365/0818
Patent Assignment
Reel/Frame 055365/0818

Assignment of Assignor's Interest

Recorded: 2021-02-23 Pages: 7
Assignor
BRISTOL-MYERS SQUIBB COMPANY
Executed: 2011-09-08
Assignee
EXELIXIS, INC.
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080-0511
Covered Properties (2)
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
Application: 17/149,365 →
Publication: US 2021/0139430
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
Application: 17/171,752 →
Publication: US 2021/0163416
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 23, 2021
From: GALLAGHER, WILLIAM P.
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 055365/0289 →
Assignment of Assignor's Interest Feb 23, 2021
From: LAMB, PETER
To: EXELIXIS, INC.
Reel/Frame 055365/0395 →
Assignment of Assignor's Interest Feb 23, 2021
From: ST. CLAIR BROWN, ADRIAN
To: PHARMORPHIX
Reel/Frame 055365/0605 →
Assignment of Assignor's Interest Feb 23, 2021
From: PHARMORPHIX
To: EXELIXIS, INC.
Reel/Frame 055365/0914 →